Abivax S.A. ( ABVX) - Stock Earnings
ABVX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Sept. 14, 2026 AfterMarket | — / — | — | — / — | — |
ABVX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -180.0 million USD | — USD |
| 2025Q4 | -337.7 million USD | -2.4 million USD |
| 2026Q1 | -55.5 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
ABVX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -163.3 million USD | 5.1 million USD |
| 2024 | -183.5 million USD | 11.2 million USD |
| 2025 | -394.6 million USD | — USD |
| 2026 Est. | — | — |
ABVX
Price: $99.44
52 week price:
Earnings Per Share: -5.36 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 5.9 billion